SCHEMBL3663698

SCHEMBL3663698

O=CC(c1ccc(Cl)cc1)c1ccccc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 5/20 0.53
TSHR P16473 4/20 0.53
HIF1A Q16665 3/20 0.53
TDP1 Q9NUW8 3/20 0.53
MAPK1 P28482 2/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
KDM4E B2RXH2 1/20 0.53
NR1I2 O75469 1/20 0.53
ABCB11 O95342 1/20 0.53
LMNA P02545 1/20 0.53
NR3C1 P04150 1/20 0.53
PGR P06401 1/20 0.53
CYP3A4 P08684 1/20 0.53
ADRA2A P08913 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
MAPT P10636 1/20 0.53
SLC6A2 P23975 1/20 0.53
ACAT1 P24752 1/20 0.53
SLC6A4 P31645 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1515735 0.89 ACP3 (0.49) CNR1TSHRHIF1ATDP1MAPK1
SCHEMBL7727749 0.84 ACP3 (0.41) CNR1TSHRHIF1ATDP1MAPK1
SCHEMBL3398965 0.82 CYP19A1 (0.39) CNR1TSHRHIF1ATDP1MAPK1
SCHEMBL13278454 0.82 CNR2 (0.42) CNR1TSHRHIF1ATDP1MAPK1
SCHEMBL4686827 0.81 TP53 (0.44) CNR1TDP1LMNAATMIDO1
SCHEMBL1515902 0.80 IDO1 (0.48) CNR1TSHRHIF1ATDP1MAPK1
SCHEMBL1978297 0.80 HSD17B10 (0.46) TSHRHIF1ATDP1MAPK1LMNA
SCHEMBL11458875 0.79 IDO1 (0.51) CNR1TDP1MAPK1LMNAMAPT
SCHEMBL8591339 0.78 ACP3 (0.44) CNR1TSHRHIF1ATDP1MAPK1
SCHEMBL3907562 0.77 ACP3 (0.39) CNR1TSHRHIF1ATDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139333-A1 SUBSTITUTED PYRIDO[3,2-E][1,2,4]TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS Merck & Co., Inc. (US) 2010-01-06 EP disclosed
WO-2008118414-A1 SUBSTITUTED PYRIDO[3,2-E][1,2,4]TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS MERCK & CO., INC. (US) 2008-10-02 WO disclosed
EP-1682550-A4 SUBSTITUTED NAPHTHYRIDINONE DERIVATIVES MERCK & CO INC (US) 2007-01-03 EP disclosed
EP-1682550-A1 SUBSTITUTED NAPHTHYRIDINONE DERIVATIVES Merck & Co., Inc. (US) 2006-07-26 EP disclosed
EP-1558252-A4 SUBSTITUTED FURO 2,3-B| PYRIDINE DERIVATIVES MERCK & CO INC (US) 2006-05-17 EP disclosed
EP-1558252-A2 SUBSTITUTED FURO 2,3-B] PYRIDINE DERIVATIVES Merck & Co., Inc. (US) 2005-08-03 EP disclosed
WO-2005047285-A1 SUBSTITUTED NAPHTHYRIDINONE DERIVATIVES MERCK & CO., INC. (US) 2005-05-26 WO disclosed
EP-1492784-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES Merck & Co., Inc. (US) 2005-01-05 EP disclosed
WO-2004012671-A2 SUBSTITUTED FURO [2,3-B] PYRIDINE DERIVATIVES MERCK & CO., INC. (US) 2004-02-12 WO disclosed
WO-2003082191-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES MERCK & CO., INC. (US) 2003-10-09 WO disclosed